UroGen Pharma Ltd (NAS:URGN)
$ 13.05 -0.76 (-5.5%) Market Cap: 549.59 Mil Enterprise Value: 437.91 Mil PE Ratio: 0 PB Ratio: 18.74 GF Score: 72/100

Urogen Pharma Ltd Annual Shareholders Meeting Transcript

Jun 08, 2020 / 01:00PM GMT
Release Date Price: $28.24 (+5.18%)
Operator

Hello, and welcome to the Annual Meeting of Shareholders of UroGen Pharma Limited. (Operator Instructions)

It is now my pleasure to turn today's meeting over to Liz Barrett, member of the Board of Directors as well as President and Chief Executive Officer of UroGen Pharma Limited. Ms. Barrett, the floor is yours.

Elizabeth A. Barrett
UroGen Pharma Ltd. - President, CEO & Director

Thank you, operator, and good morning, everyone. My name is Liz Barrett, and I'm a member of the Board of Directors as well as President and Chief Executive Officer of UroGen Pharma. I am very happy to welcome you to the 2020 Annual Meeting of Shareholders of UroGen Pharma.

The meeting will now officially come to order. The time is now 9:01 a.m. on June 8, 2020, and the polls are now open for voting for all matters to be presented. As you know, we are hosting today's meeting through a virtual online platform hosted by Computershare.

Before we proceed with the formal business of the meeting, I'd like to introduce you to the members of the Board and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot